Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities.

Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities.

Item
http://www.wikidata.org/entity/Q37223344
GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell diseaseHydroxyurea is associated with lower costs of care of young children with sickle cell anemiaAdherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.Do difficulties in swallowing medication impede the use of hydroxyurea in children?Rationale and design of mDOT-HuA study: a randomized trial to assess the effect of mobile-directly observed therapy on adherence to hydroxyurea in adults with sickle cell anemia in Tanzania.Evaluation of renal function in sickle cell disease patients in Brazil.Translating sickle cell guidelines into practice for primary care providers with Project ECHO.Health-related quality of life in sickle cell disease: past, present, and future.Decreased fetal hemoglobin over time among youth with sickle cell disease on hydroxyurea is associated with higher urgent hospital use.Increased risk of leukemia among sickle cell disease patients in California.Effect of Hydroxyurea Therapy on Pulmonary Function in Children with Sickle Cell Anemia.Adaptation of a microbead assay for the easy evaluation of traditional anti-sickling medicines: application to DREPANOSTAT and FACA
P2860

Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities.

Item
http://www.wikidata.org/entity/Q37223344
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hydroxyurea use in sickle cell ...... iance and fears of toxicities.
@en
Hydroxyurea use in sickle cell ...... iance and fears of toxicities.
@nl
type
label
Hydroxyurea use in sickle cell ...... iance and fears of toxicities.
@en
Hydroxyurea use in sickle cell ...... iance and fears of toxicities.
@nl
prefLabel
Hydroxyurea use in sickle cell ...... iance and fears of toxicities.
@en
Hydroxyurea use in sickle cell ...... iance and fears of toxicities.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Hydroxyurea use in sickle cell ...... iance and fears of toxicities.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932